CARYX
Price
$9.60
Change
+$0.03 (+0.31%)
Updated
Apr 25 closing price
Net Assets
2.35B
UTMAX
Price
$10.30
Change
+$0.05 (+0.49%)
Updated
Apr 25 closing price
Net Assets
433.38M
Ad is loading...

CARYX vs UTMAX

Header iconCARYX vs UTMAX Comparison
Open Charts CARYX vs UTMAXBanner chart's image
Columbia Adaptive Risk Allocation Inst3
Price$9.60
Change+$0.03 (+0.31%)
VolumeN/A
Net Assets2.35B
Victory Target Managed Allocation
Price$10.30
Change+$0.05 (+0.49%)
VolumeN/A
Net Assets433.38M
CARYX vs UTMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CARYX vs. UTMAX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARYX is a Hold and UTMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CARYX has more cash in the bank: 2.35B vs. UTMAX (433M). CARYX pays higher dividends than UTMAX: CARYX (2.53) vs UTMAX (1.66). CARYX was incepted earlier than UTMAX: CARYX (11 years) vs UTMAX (10 years). CARYX (0.77) is less costly to investors than UTMAX (0.69). CARYX is a more actively managed with annual turnover of: 190.00 vs. UTMAX (148.00). UTMAX has a lower initial minimum investment than CARYX: UTMAX (0) vs CARYX (1000000). CARYX annual gain was more profitable for investors over the last year : 7.74 vs. UTMAX (4.10). UTMAX return over 5 years is better than : 11.06 vs. CARYX (9.02).
CARYXUTMAXCARYX / UTMAX
Total Expense Ratio0.770.69112%
Annual Report Gross Expense Ratio0.770.69112%
Fund Existence11 years10 years-
Gain YTD0.000-4.026-
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.35B433M542%
Annual Yield % from dividends2.531.66153%
Returns for 1 year7.744.10189%
Returns for 3 years7.815.99130%
Returns for 5 years9.0211.0682%
Returns for 10 years15.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFQTX17.09N/A
N/A
AMG Veritas Global Focus I
RYANX115.61N/A
N/A
Rydex Nova A
BMRRX31.47N/A
N/A
BlackRock Mid-Cap Growth Equity R
CBBZX6.20N/A
N/A
AB Relative Value Z
PDEZX17.09N/A
N/A
PGIM Jennison Emerging Markets Eq Opps Z